Volume 15, Number 9—September 2009
Extrapulmonary Infections Associated with Nontuberculous Mycobacteria in Immunocompetent Persons
MedscapeCME is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit. This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of MedscapeCME and Emerging Infectious Diseases. MedscapeCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. MedscapeCME designates this educational activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation at http://www.medscape.com/cme/eid; (4) view/print certificate.
• Upon completion of this activity, participants will be able to:
• Diagnose and treat nontuberculous mycobacterial (NTM) lymphadenitis effectively
• Identify elements of NTM osteoarticular infections
• Treat NTM skin infections according to standards of care
• Describe infections with rapidly growing mycobacteria
P. Lynne Stockton, VMD, MS, Copyeditor, Emerging Infectious Diseases. Disclosure: P. Lynne Stockton, VMD, MS, has disclosed no relevant financial relationships.
Charles P. Vega, MD, FAAFP, Associate Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, FAAFP, has disclosed no relevant financial relationships.
Disclosures: Claudio Piersimoni, MD; and Claudio Scarparo, MD, have disclosed no relevant financial relationships.